Clinical trial
Beta Blocker for Chronic Wound Healing
NCT00368602 · University of California, Davis, Other · Terminated
Key facts
| NCT number | NCT00368602 |
|---|---|
| Title | Beta Blocker for Chronic Wound Healing |
| Official title | Beta Adrenergic Receptor Modulation of Burn Wound Healing |
| Lead sponsor | University of California, Davis, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ulcer, Burns |
| Intervention type | Drug, Other |
| Interventions | Timoptic, Placebo |
| Enrollment | 40 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Aug 25, 2006 |
| Last update posted | Apr 7, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: